Lincoln Pharmaceuticals Limited (NSE:LINCOLN)
India · Delayed Price · Currency is INR 604.90
+10.05 (1.69%)
Apr 2, 2026, 3:29 PM IST
Lincoln Pharmaceuticals Revenue
Lincoln Pharmaceuticals had revenue of 1.66B INR in the quarter ending December 31, 2025, with 13.49% growth. This brings the company's revenue in the last twelve months to 6.52B, up 9.10% year-over-year. In the fiscal year ending March 31, 2025, Lincoln Pharmaceuticals had annual revenue of 6.23B with 7.35% growth.
Revenue (ttm)
6.52B
Revenue Growth
+9.10%
P/S Ratio
1.88
Revenue / Employee
3.52M
Employees
1,853
Market Cap
12.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6.23B | 426.81M | 7.35% |
| Mar 31, 2024 | 5.81B | 702.41M | 13.76% |
| Mar 31, 2023 | 5.10B | 381.86M | 8.09% |
| Mar 31, 2022 | 4.72B | 479.38M | 11.30% |
| Mar 31, 2021 | 4.24B | 376.95M | 9.75% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 17.60B |
| Solara Active Pharma Sciences | 12.55B |
| Windlas Biotech | 8.68B |
| Orchid Pharma | 8.11B |
| RPG Life Sciences | 6.74B |
| Ind-Swift Laboratories | 5.94B |
| Sigachi Industries | 4.85B |
| Beta Drugs | 3.85B |
Lincoln Pharmaceuticals News
- 9 months ago - Lincoln Pharmaceuticals successfully completes trial run at new API facility in Gujarat - Business Upturn